These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 17220911)

  • 1. Statins induce S1P1 receptors and enhance endothelial nitric oxide production in response to high-density lipoproteins.
    Igarashi J; Miyoshi M; Hashimoto T; Kubota Y; Kosaka H
    Br J Pharmacol; 2007 Feb; 150(4):470-9. PubMed ID: 17220911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial lipase is a critical determinant of high-density lipoprotein-stimulated sphingosine 1-phosphate-dependent signaling in vascular endothelium.
    Tatematsu S; Francis SA; Natarajan P; Rader DJ; Saghatelian A; Brown JD; Michel T; Plutzky J
    Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1788-94. PubMed ID: 23723371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of endothelial nitric oxide synthase activation in endothelial cells by S1P1 and S1P3.
    Tölle M; Klöckl L; Wiedon A; Zidek W; van der Giet M; Schuchardt M
    Biochem Biophys Res Commun; 2016 Aug; 476(4):627-634. PubMed ID: 27282481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostacyclin induction by high-density lipoprotein (HDL) in vascular smooth muscle cells depends on sphingosine 1-phosphate receptors: effect of simvastatin.
    González-Díez M; Rodríguez C; Badimon L; Martínez-González J
    Thromb Haemost; 2008 Jul; 100(1):119-26. PubMed ID: 18612546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrogen peroxide induces S1P1 receptors and sensitizes vascular endothelial cells to sphingosine 1-phosphate, a platelet-derived lipid mediator.
    Igarashi J; Miyoshi M; Hashimoto T; Kubota Y; Kosaka H
    Am J Physiol Cell Physiol; 2007 Feb; 292(2):C740-8. PubMed ID: 16943246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.
    Hernández-Perera O; Pérez-Sala D; Navarro-Antolín J; Sánchez-Pascuala R; Hernández G; Díaz C; Lamas S
    J Clin Invest; 1998 Jun; 101(12):2711-9. PubMed ID: 9637705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells.
    Jantzen F; Könemann S; Wolff B; Barth S; Staudt A; Kroemer HK; Dahm JB; Felix SB; Landsberger M
    J Physiol Pharmacol; 2007 Sep; 58(3):503-14. PubMed ID: 17928646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of different statins on endothelin-1 gene expression and endothelial NOS phosphorylation in porcine aortic endothelial cells.
    Ohkita M; Sugii M; Ka Y; Kitamura A; Mori T; Hayashi T; Takaoka M; Matsumura Y
    Exp Biol Med (Maywood); 2006 Jun; 231(6):772-6. PubMed ID: 16740997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance.
    Feron O; Dessy C; Desager JP; Balligand JL
    Circulation; 2001 Jan; 103(1):113-8. PubMed ID: 11136695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosine 1-phosphate induces endothelial nitric-oxide synthase activation through phosphorylation in human corpus cavernosum.
    di Villa Bianca Rd; Sorrentino R; Sorrentino R; Imbimbo C; Palmieri A; Fusco F; Maggi M; De Palma R; Cirino G; Mirone V
    J Pharmacol Exp Ther; 2006 Feb; 316(2):703-8. PubMed ID: 16234413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute activation of eNOS by statins involves scavenger receptor-B1, G protein subunit Gi, phospholipase C and calcium influx.
    Datar R; Kaesemeyer WH; Chandra S; Fulton DJ; Caldwell RW
    Br J Pharmacol; 2010 Aug; 160(7):1765-72. PubMed ID: 20649578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingosine 1-phosphate (S1P) carrier-dependent regulation of endothelial barrier: high density lipoprotein (HDL)-S1P prolongs endothelial barrier enhancement as compared with albumin-S1P via effects on levels, trafficking, and signaling of S1P1.
    Wilkerson BA; Grass GD; Wing SB; Argraves WS; Argraves KM
    J Biol Chem; 2012 Dec; 287(53):44645-53. PubMed ID: 23135269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3-hydroxy-3-methylglutaryl coenzyme A reductase-independent inhibition of CD40 expression by atorvastatin in human endothelial cells.
    Wagner AH; Gebauer M; Güldenzoph B; Hecker M
    Arterioscler Thromb Vasc Biol; 2002 Nov; 22(11):1784-9. PubMed ID: 12426205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosine-1-phosphate: metabolism, transport, atheroprotection and effect of statin treatment.
    Therond P; Chapman MJ
    Curr Opin Lipidol; 2022 Jun; 33(3):199-207. PubMed ID: 35695616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pitavastatin at low dose activates endothelial nitric oxide synthase through PI3K-AKT pathway in endothelial cells.
    Wang J; Tokoro T; Matsui K; Higa S; Kitajima I
    Life Sci; 2005 Mar; 76(19):2257-68. PubMed ID: 15733940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation.
    Wagner AH; Köhler T; Rückschloss U; Just I; Hecker M
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):61-9. PubMed ID: 10634801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin-induced expression of decay-accelerating factor protects vascular endothelium against complement-mediated injury.
    Mason JC; Ahmed Z; Mankoff R; Lidington EA; Ahmad S; Bhatia V; Kinderlerer A; Randi AM; Haskard DO
    Circ Res; 2002 Oct; 91(8):696-703. PubMed ID: 12386146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins.
    Brouet A; Sonveaux P; Dessy C; Moniotte S; Balligand JL; Feron O
    Circ Res; 2001 Nov; 89(10):866-73. PubMed ID: 11701613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingosine 1-phosphate and activation of endothelial nitric-oxide synthase. differential regulation of Akt and MAP kinase pathways by EDG and bradykinin receptors in vascular endothelial cells.
    Igarashi J; Bernier SG; Michel T
    J Biol Chem; 2001 Apr; 276(15):12420-6. PubMed ID: 11278407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atorvastatin and pitavastatin enhance lipoprotein lipase production in L6 skeletal muscle cells through activation of adenosine monophosphate-activated protein kinase.
    Ohira M; Endo K; Saiki A; Miyashita Y; Terai K; Murano T; Watanabe F; Tatsuno I; Shirai K
    Metabolism; 2012 Oct; 61(10):1452-60. PubMed ID: 22520230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.